Vein Clinics of America Opens New Location in Monroeville, Pa
MONROEVILLE, Pa.--([ BUSINESS WIRE ])--IntegraMed America, Inc. (NASDAQ: INMD), the nation's leading provider of specialty healthcare services in emerging, technology-focused segments, announced today that its wholly owned subsidiary, Vein Clinics of America (VCA), is opening its 31st vein clinic location. Located at 400 Penn Center Blvd. in Monroeville, Pennsylvania, the new office will offer the latest in vein disease diagnosis and treatment.
Ted King, M.D., medical director of VCA, commented, "Treatment options for vein disease continue to advance as the use of laser and other non-surgical technologies take on a more prominent role. It is rewarding for both physicians and patients to see the positive results we are able to achieve to cure our patients from the discomfort and pain brought on by this progressive condition."
Vein disease is a potentially serious medical condition, which if ignored may result in symptoms such as pain, fatigue, itching, burning and swelling. Patients may also experience throbbing and restlessness, feeling the need to constantly keep their legs moving. Left untreated by a medical professional, vein disease often worsens and becomes a major health concern.
"Minimally invasive techniques for the treatment of vein disease offer not just an improved quality of life both physically and health-wise, but also afford a greater sense of confidence and well-being to our patients," stated Anthony D'Alessio, M.D., practicing physician at VCA's Monroeville office.
VCA has over 25 years of experience in the vein care field, specializing in all aspects of vein disease, including varicose veins, spider veins and leg ulcers. Offering a comprehensive, non-surgical treatment approach, the average patient requires sclerotherapy injection treatment in conjunction with Endovenous Laser Treatment (ELT) to treat the smaller veins. VCA's use of sclerotherapy in combination with ELT allows physicians to treat from the smallest spider veins to the largest ropelike varicose veins, including leg ulcers. All procedures are performed in the physician's office with no surgery or post hospitalization required. To schedule a consultation, please call toll-free 1-800-660-VEIN.
About IntegraMed America, Inc.
IntegraMed America, Inc. is the leading operator of fertility centers and vein care clinics in the United States. The Company supports its provider networks with state-of-the art information systems; marketing and payer contracting; financial planning, reporting and analysis; organizational planning and development; quality assurance initiatives; human resources administration; and purchasing services. IntegraMed also offers consumer treatment-financing programs and operates [ www.integramed.com ], a leading fertility portal.
The IntegraMed Fertility network consists of 33 contracted centers in 109 locations across the United States, including 191 physicians and Ph.D. scientists. One of every five IVF procedures in the U.S. is performed in an IntegraMed fertility practice. The IntegraMed Vein Clinic network is the leading provider of vein care services in the US and operates 31 centers in 12 states, principally in the Midwest and Southeast.
About Vein Clinics of America, Inc.
Established in 1981, Vein Clinics of America, Inc. (VCA) is the largest medical group in the country dedicated to the non-surgical treatment of vein disorders. The physicians of VCA specialize in treating the entire spectrum of vein abnormalities, including varicose veins, spider veins, venous leg ulcers, facial veins, hand veins, Klippel-Trenaunay Syndrome and Restless Legs Syndrome resulting from venous reflux. VCA is a wholly owned subsidiary of IntegraMed, America, Inc, the leading operator of fertility centers and vein care clinics in the United States. VCA is based in Downers Grove, Ill. with operations in Florida, Georgia, Illinois, Indiana, Kansas, Maryland, Missouri, North Carolina, Pennsylvania, Tennessee, Virginia and Wisconsin and operates [ www.veinclinics.com ], a leading vein care portal.
Statements contained in this press release that are not based on historical fact, including statements concerning future results, performance, expectations and expansion of IntegraMed are forward-looking statements that may involve a number of risks and uncertainties.Actual results may differ materially from the statements made as a result of various factors, including, but not limited to, the risks associated with IntegraMed's ability to finance future growth; changes in insurance coverage, government laws and regulations regarding health care or managed care contracting; and other risks, including those identified in the company's most recent Form 10-K and in other documents filed by IntegraMed with the U.S. Securities and Exchange Commission.All information in this press release is as of December 8, 2008 and IntegraMed undertakes no duty to update this information.